Cargando…

Heterologous SARS-CoV-2 spike protein booster elicits durable and broad antibody responses against the receptor-binding domain

The immunogenicity of mRNA vaccines has not been well studied when compared to different vaccine modalities in the context of additional boosters. Here we show that longitudinal analysis reveals more sustained SARS-CoV-2 spike receptor-binding domain (RBD)-binding IgG titers with the breadth to anti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takano, Tomohiro, Sato, Takashi, Kotaki, Ryutaro, Moriyama, Saya, Fukushi, Shuetsu, Shinoda, Masahiro, Kabasawa, Kiyomi, Shimada, Nagashige, Kousaka, Mio, Adachi, Yu, Onodera, Taishi, Terahara, Kazutaka, Isogawa, Masanori, Matsumura, Takayuki, Shinkai, Masaharu, Takahashi, Yoshimasa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10016167/ https://www.ncbi.nlm.nih.gov/pubmed/36922492 http://dx.doi.org/10.1038/s41467-023-37128-1

Ejemplares similares

SARS-CoV-2 Omicron-neutralizing memory B-cells are elicited by two doses of BNT162b2 mRNA vaccine
por: Kotaki, Ryutaro, et al.
Publicado: (2022)

Distinct immune cell dynamics correlate with the immunogenicity and reactogenicity of SARS-CoV-2 mRNA vaccine
por: Takano, Tomohiro, et al.
Publicado: (2022)

CD62L expression marks SARS-CoV-2 memory B cell subset with preference for neutralizing epitopes
por: Onodera, Taishi, et al.
Publicado: (2023)

SARS-CoV-2-specific CD4(+) T cell longevity correlates with Th17-like phenotype
por: Terahara, Kazutaka, et al.
Publicado: (2022)

Humoral immunity for durable control of SARS-CoV-2 and its variants
por: Kotaki, Ryutaro, et al.
Publicado: (2023)

A case of reinfection with a different variant of SARS-CoV-2: case report
por: Shimada, Nagashige, et al.
Publicado: (2023)

Temporal maturation of neutralizing antibodies in COVID-19 convalescent individuals improves potency and breadth to circulating SARS-CoV-2 variants
por: Moriyama, Saya, et al.
Publicado: (2021)

Non-Omicron breakthrough infection with higher viral load and longer vaccination-infection interval improves SARS-CoV-2 BA.4/5 neutralization
por: Miyamoto, Sho, et al.
Publicado: (2023)

Longitudinal Analysis of Neutralizing Potency against SARS-CoV-2 in the Recovered Patients after Treatment with or without Favipiravir
por: Shinada, Kanako, et al.
Publicado: (2022)

Structural delineation and computational design of SARS-CoV-2-neutralizing antibodies against Omicron subvariants
por: Moriyama, Saya, et al.
Publicado: (2023)

A CCR5(+) memory subset within HIV-1-infected primary resting CD4(+) T cells is permissive for replication-competent, latently infected viruses in vitro
por: Terahara, Kazutaka, et al.
Publicado: (2019)

Correction to: A CCR5(+) memory subset within HIV-1-infected primary resting CD4(+) T cells is permissive for replication-competent, latently infected viruses in vitro
por: Terahara, Kazutaka, et al.
Publicado: (2019)

Glycan engineering of the SARS-CoV-2 receptor-binding domain elicits cross-neutralizing antibodies for SARS-related viruses
por: Shinnakasu, Ryo, et al.
Publicado: (2021)

Perspectives on Non-BLT Humanized Mouse Models for Studying HIV Pathogenesis and Therapy
por: Terahara, Kazutaka, et al.
Publicado: (2021)

Safety and immunogenicity of the Pfizer/BioNTech SARS-CoV-2 mRNA third booster vaccine dose against the BA.1 and BA.2 Omicron variants
por: Seki, Yohei, et al.
Publicado: (2022)

Development of an Inflammatory CD14(+) Dendritic Cell Subset in Humanized Mice
por: Iwabuchi, Ryutaro, et al.
Publicado: (2021)

Esophagectasis Related to Rivastigmine
por: Sasaki, Osamu, et al.
Publicado: (2019)

Asymptomatic ceftriaxone‐associated pseudolithiasis
por: Sasaki, Osamu, et al.
Publicado: (2019)

Solithromycin inhibits IL-13-induced goblet cell hyperplasia and MUC5AC, CLCA1, and ANO1 in human bronchial epithelial cells
por: Kimura, Yasuhiro, et al.
Publicado: (2023)

Pseudotyped Vesicular Stomatitis Virus for Analysis of Virus Entry Mediated by SARS Coronavirus Spike Proteins
por: Fukushi, Shuetsu, et al.
Publicado: (2007)

Vaccination-infection interval determines cross-neutralization potency to SARS-CoV-2 Omicron after breakthrough infection by other variants
por: Miyamoto, Sho, et al.
Publicado: (2022)

A SARS-CoV-2 antibody broadly neutralizes SARS-related coronaviruses and variants by coordinated recognition of a virus-vulnerable site
por: Onodera, Taishi, et al.
Publicado: (2021)

Introduction of Human Flt3-L and GM-CSF into Humanized Mice Enhances the Reconstitution and Maturation of Myeloid Dendritic Cells and the Development of Foxp3(+)CD4(+) T Cells
por: Iwabuchi, Ryutaro, et al.
Publicado: (2018)

Durability of Heterologous and Homologous COVID-19 Vaccine Boosts
por: Tan, C. Sabrina, et al.
Publicado: (2022)

Receptor Usage and the Pathogenesis in Acute and Chronic Virus Infections
por: Tsunetsugu-Yokota, Yasuko, et al.
Publicado: (2012)

Calibrating Hepatitis E Virus Serological Assays Using Asymptomatic Specimens Obtained in Japan
por: Terahara, Kazutaka, et al.
Publicado: (2022)

Possibility of underestimation of COVID-19 prevalence by PCR and serological tests
por: Ota, Shinichiro, et al.
Publicado: (2022)

Detection of silent infection of severe acute respiratory syndrome coronavirus 2 by serological tests
por: Nishimura, Masashi, et al.
Publicado: (2022)

Different efficacies of neutralizing antibodies and antiviral drugs on SARS-CoV-2 Omicron subvariants, BA.1 and BA.2
por: Ohashi, Hirofumi, et al.
Publicado: (2022)

Saturation time of exposure interval for cross-neutralization response to SARS-CoV-2: Implications for vaccine dose interval
por: Miyamoto, Sho, et al.
Publicado: (2023)

Virulence, pathology, and pathogenesis of Pteropine orthoreovirus (PRV) in BALB/c mice: Development of an animal infection model for PRV
por: Egawa, Kazutaka, et al.
Publicado: (2017)

A novel M cell–specific carbohydrate-targeted mucosal vaccine effectively induces antigen-specific immune responses
por: Nochi, Tomonori, et al.
Publicado: (2007)

Assessment of Fcγ receptor-dependent binding of influenza hemagglutinin vaccine-induced antibodies in a non-human primate model
por: Masuta, Yuji, et al.
Publicado: (2022)

Serological Assays Based on Recombinant Viral Proteins for the Diagnosis of Arenavirus Hemorrhagic Fevers
por: Fukushi, Shuetsu, et al.
Publicado: (2012)

Phosphorylation of p38 MAPK and its downstream targets in SARS coronavirus-infected cells
por: Mizutani, Tetsuya, et al.
Publicado: (2004)

Importance of Akt signaling pathway for apoptosis in SARS-CoV-infected Vero E6 cells
por: Mizutani, Tetsuya, et al.
Publicado: (2004)

Regulation of p90RSK phosphorylation by SARS‐CoV infection in Vero E6 cells
por: Mizutani, Tetsuya, et al.
Publicado: (2006)

Characterization of Persistent SARS-CoV Infection in Vero E6 Cells
por: Mizutani, Tetsuya, et al.
Publicado: (2006)

JNK and PI3k/Akt signaling pathways are required for establishing persistent SARS-CoV infection in Vero E6 cells
por: Mizutani, Tetsuya, et al.
Publicado: (2005)

Saliva as a useful tool for evaluating upper mucosal antibody response to influenza
por: Tsunetsugu-Yokota, Yasuko, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8frp76rl59q0ff7antfii8abht